Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Garrett

Showing results (41-50 of 224) with videos related to

Pageof 23
Sort By:
Aerospace Medicine|April 1, 1971
Role of anthropology in Air Force systemsM Alexander, J W Garrett, J C Robinette
Hematology. American Society of Hematology. Education Program|November 25, 2004
Supportive careJohn R Wingard, W Garrett Nichols, George B McDonald
Abdominal Radiology (New York)|April 28, 2025
Methodology for a fully automated pipeline of AI-based body composition tools for abdominal CTJohn W Garrett, Perry J Pickhardt, Ronald M Summers
Korean Journal of Radiology|November 1, 2021
Automated CT-Based Body Composition Analysis: A Golden OpportunityPerry J Pickhardt, Ronald M Summers, John W Garrett
Journal of Immigrant and Minority Health|January 8, 2009
Lessons learned from two school tuberculosis investigationsShu-Hua Wang, W Garrett Hunt, Dwight A Powell
Clinical Microbiology Reviews|April 11, 2008
Respiratory viruses other than influenza virus: impact and therapeutic advancesW Garrett Nichols, Angela J Peck Campbell, Michael Boeckh
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|July 5, 2024
Predictors of early secondary IOL implantation after pediatric cataract surgeryW Garrett Hayes, M Edward Wilson, Rupal H Trivedi
Annals of Ophthalmology|May 1, 1988
Adrenocorticosteroid injection vs. conservative therapy in the treatment of chalaziaG W Garrett, M E Gillespie, B C Mannix
Antiviral Research|January 18, 2017
Short-term clinical safety profile of brincidofovir: A favorable benefit-risk proposition in the treatment of smallpoxGreg Chittick, Marion Morrison, Thomas Brundage, et al.
Anti-Cancer Drug Design|October 2, 1998
The 5-nitrofuran-2-ylmethylidene group as a potential bioreductively activated prodrug system for diol-containing drugsN P Mahmud, S W Garrett, M D Threadgill
Pageof 23

Showing results (41-50 of 224) with videos related to

Sort By:
Pageof 23
Aerospace Medicine|April 1, 1971
Role of anthropology in Air Force systemsM Alexander, J W Garrett, J C Robinette
Hematology. American Society of Hematology. Education Program|November 25, 2004
Supportive careJohn R Wingard, W Garrett Nichols, George B McDonald
Abdominal Radiology (New York)|April 28, 2025
Methodology for a fully automated pipeline of AI-based body composition tools for abdominal CTJohn W Garrett, Perry J Pickhardt, Ronald M Summers
Korean Journal of Radiology|November 1, 2021
Automated CT-Based Body Composition Analysis: A Golden OpportunityPerry J Pickhardt, Ronald M Summers, John W Garrett
Journal of Immigrant and Minority Health|January 8, 2009
Lessons learned from two school tuberculosis investigationsShu-Hua Wang, W Garrett Hunt, Dwight A Powell
Clinical Microbiology Reviews|April 11, 2008
Respiratory viruses other than influenza virus: impact and therapeutic advancesW Garrett Nichols, Angela J Peck Campbell, Michael Boeckh
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|July 5, 2024
Predictors of early secondary IOL implantation after pediatric cataract surgeryW Garrett Hayes, M Edward Wilson, Rupal H Trivedi
Annals of Ophthalmology|May 1, 1988
Adrenocorticosteroid injection vs. conservative therapy in the treatment of chalaziaG W Garrett, M E Gillespie, B C Mannix
Antiviral Research|January 18, 2017
Short-term clinical safety profile of brincidofovir: A favorable benefit-risk proposition in the treatment of smallpoxGreg Chittick, Marion Morrison, Thomas Brundage, et al.
Anti-Cancer Drug Design|October 2, 1998
The 5-nitrofuran-2-ylmethylidene group as a potential bioreductively activated prodrug system for diol-containing drugsN P Mahmud, S W Garrett, M D Threadgill
Pageof 23